Clinical Trial Update: TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tranexamic acid therapy for bleeding in thrombocytopenia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Thrombocytopenia

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: NHS Blood and Transplant | Conditions: Hematologic Neoplasms, Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2025-10-28